Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 25, 2021 at 05:24 pm IST
Share
Huaren Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 4,097.11 million compared to CNY 1,012.81 million a year ago. Revenue was CNY 4,097.11 million compared to CNY 1,012.81 million a year ago. Net income was CNY 117.29 million compared to CNY 54.1 million a year ago. Basic earnings per share from continuing operations was CNY 0.0992 compared to CNY 0.0458 a year ago. Diluted earnings per share from continuing operations was CNY 0.0992 compared to CNY 0.0458 a year ago.
Huaren Pharmaceutical CO.,LTD is a China-based company principally engaged in the research, development, manufacture and distribution of non polyvinyl chloride (PVC) soft bag large volume preparations. The Company provides basic infusion products, including sodium chloride infusions, dextrose infusions and compound sodium chloride infusions, among others; infusion products for treatment, including metronidazole and sodium chloride infusions, ciprofloxacin lactate and sodium chloride infusions and others, as well as nutritious infusion products, among others. The Company distributes its products in domestic market, with Northeast China as its main market.